Antithrombotic therapy in the new millennium - The role of low-molecular-weight heparin

Low-molecular-weight heparins (LMWHs) are among the most rigorously tested agents in the management of thrombo-embolic disease. The evidence is accumulating that they represent a major advance in the management of arterial and venous thrombo-embolism, and within the next year or two they will replace standard heparin for virtually every indication for which heparin is currently indicated. In the management of acute coronary ischaemia, the …